Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)
1,432.00
0.00 (0.00%)
At close: Oct 27, 2026
CBSE:PRO Revenue
Societe de Promotion Pharmaceutique du Maghreb had revenue of 507.06M MAD in the half year ending June 30, 2026, with 16.85% growth. This brings the company's total for the last twelve months to 1.02B, up 10.07% year-over-year. In the year 2025, Societe de Promotion Pharmaceutique du Maghreb had annual revenue of 979.73M with 9.02% growth. That makes Societe de Promotion Pharmaceutique du Maghreb the 22,388th largest company in the world by revenue and 51st in Morocco.
Revenue (ttm)
1.02B
Revenue Growth
+10.07%
P/S Ratio
1.40
Revenue / Employee
2.98M
Employees
343
Market Cap
1.43B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 979.73M | 81.02M | 9.02% |
| Dec 31, 2024 | 898.71M | 93.20M | 11.57% |
| Dec 31, 2023 | 805.52M | 100.88M | 14.32% |
| Dec 31, 2022 | 704.64M | 74.15M | 11.76% |
| Dec 31, 2021 | 630.49M | 57.30M | 10.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Société Maghrébine de Crédit-bail | 4.36B |
| Maroc Leasing | 4.11B |
| Disway | 2.21B |
| Mutandis SCA | 2.08B |
| Microdata | 1.32B |
| Unimer | 1.14B |
| Dari Couspate | 818.40M |
| Salafin | 713.45M |